Literature DB >> 6799644

Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.

V Elharrar, D P Zipes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799644

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  9 in total

Review 1.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

2.  Stereoselective genetically-determined interaction between chronic flecainide and quinidine in patients with arrhythmias.

Authors:  U M Birgersdotter; W Wong; J Turgeon; D M Roden
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.

Authors:  P D Hemsworth; T J Campbell
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

4.  Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.

Authors:  E L Carey; H J Duff; D M Roden; R K Primm; G R Wilkinson; T Wang; J A Oates; R L Woosley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

Review 5.  Encainide.

Authors:  M J Antonaccio; A W Gomoll; J E Byrne
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

6.  Pharmacokinetics of encainide in patients with cirrhosis.

Authors:  G Wensing; H Mönig; E E Ohnhaus; H P Hoensch
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 7.  Clinical pharmacokinetics of encainide.

Authors:  D M Roden; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 8.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 9.  Encainide. A review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.